The state of Texas currently has 50 active clinical trials seeking participants for Hypertension research studies. These trials are conducted in various cities, including Houston, Dallas, San Antonio and Austin.
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
NCT03298802
Recruiting
Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.
Gender:
FEMALE
Ages:
Between 18 years and 50 years
Trial Updated:
12/01/2023
Locations: St. David's North Austin Medical Center, Austin, Texas +1 locations
Conditions: Pre-Eclampsia, Gestational Hypertension, Superimposed Pre-Eclampsia, Hypertension, Pregnancy-Induced, Postpartum Pregnancy-Induced Hypertension, Postpartum Preeclampsia
Register for Updates
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
NCT05401357
Recruiting
This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonstrate bioequivalence with clinical endpoint in subjects with chronic open-angle glaucoma or ocular hypertension in both eyes. Test Product - Bimatoprost ophthalmic solution, 0.01% of Amneal EU, Limited Reference Product - LUMIGAN® (bimatoprost ophthalmic solution) 0.01% of Allergan, Inc.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/09/2022
Locations: Keystone Research, Austin, Texas +1 locations
Conditions: Glaucoma, Open-Angle, Ocular Hypertension
Register for Updates